Article info

Original research
PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8+T cells and promoting fatty acid metabolism

Authors

  • Pu Sun Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, ChinaUniversity of Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  • Xi Zhang Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Rong-Jing Wang University of Chinese Academy of Sciences, Beijing, ChinaKey Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Qing-Yang Ma Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Lan Xu Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Yi Wang Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Hui-Ping Liao Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Hai-Long Wang Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Lan-Dian Hu Key Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Xiangyin Kong University of Chinese Academy of Sciences, Beijing, ChinaKey Laboratory of Tissue Microenvironment and Tumor, Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Jian Ding University of Chinese Academy of Sciences, Beijing, ChinaDivision of Anti-tumor Pharmacology, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China PubMed articlesGoogle scholar articles
  • Ling-Hua Meng Division of Anti-tumor Pharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, ChinaUniversity of Chinese Academy of Sciences, Beijing, China PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Xiangyin Kong; xykong{at}sibs.ac.cn; Dr Jian Ding; jding{at}simm.ac.cn; Dr Ling-Hua Meng; lhmeng{at}simm.ac.cn
View Full Text

Citation

Sun P, Zhang X, Wang R, et al
PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8+T cells and promoting fatty acid metabolism

Publication history

  • Accepted July 16, 2021
  • First published August 9, 2021.
Online issue publication 
November 02, 2022
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.